Cargando…

Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy

INTRODUCTION: To investigate the relationship between intraocular pressure (IOP)-lowering success of selective laser trabeculoplasty (SLT) and combined phacoemulsification/Kahook Dual Blade (phaco/KDB) goniotomy in eyes with mild to severe open angle glaucoma (OAG). METHODS: Eyes undergoing combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Stephen S., Patnaik, Jennifer L., Capitena Young, Cara E., Ertel, Monica K., SooHoo, Jeffrey R., Seibold, Leonard K., Kahook, Malik Y., Pantcheva, Mina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437157/
https://www.ncbi.nlm.nih.gov/pubmed/35922711
http://dx.doi.org/10.1007/s40123-022-00554-3
_version_ 1784781523919044608
author Phillips, Stephen S.
Patnaik, Jennifer L.
Capitena Young, Cara E.
Ertel, Monica K.
SooHoo, Jeffrey R.
Seibold, Leonard K.
Kahook, Malik Y.
Pantcheva, Mina B.
author_facet Phillips, Stephen S.
Patnaik, Jennifer L.
Capitena Young, Cara E.
Ertel, Monica K.
SooHoo, Jeffrey R.
Seibold, Leonard K.
Kahook, Malik Y.
Pantcheva, Mina B.
author_sort Phillips, Stephen S.
collection PubMed
description INTRODUCTION: To investigate the relationship between intraocular pressure (IOP)-lowering success of selective laser trabeculoplasty (SLT) and combined phacoemulsification/Kahook Dual Blade (phaco/KDB) goniotomy in eyes with mild to severe open angle glaucoma (OAG). METHODS: Eyes undergoing combined phaco/KDB goniotomy and that had previously undergone SLT were analyzed. Data collected included demographics, glaucoma type and severity, IOP, and topical IOP-lowering medications before and after both procedures. Eyes were divided into two groups based on success of SLT, defined as IOP reduction of at least 20% maintained on at least two consecutive follow-up visits without any subsequent medication additions or interventions. Phaco/KDB goniotomy success was defined as IOP reduction of at least 20% and/or reduction in the number of IOP-lowering medications of at least one up to 12 months of follow-up. RESULTS: Overall, SLT was successful in 20 of 43 eyes (46.5%), of which 63.6% (7/11) had successful phaco/KDB goniotomy at 12 months follow-up. Among eyes with unsuccessful SLT, 60.0% (9/15) had successful phaco/KDB at 12 months follow-up. Phaco/KDB success rate was similar in patients regardless of their previous response to SLT at all postoperative time points up to 12 months follow-up (p = 0.87). CONCLUSIONS: The presence or lack of IOP-lowering response to SLT did not influence the success rate of subsequent phaco/KDB goniotomy in eyes with mild to severe OAG. Patients who did not respond to SLT still benefited from phaco/KDB goniotomy at a later date.
format Online
Article
Text
id pubmed-9437157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-94371572022-09-03 Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy Phillips, Stephen S. Patnaik, Jennifer L. Capitena Young, Cara E. Ertel, Monica K. SooHoo, Jeffrey R. Seibold, Leonard K. Kahook, Malik Y. Pantcheva, Mina B. Ophthalmol Ther Original Research INTRODUCTION: To investigate the relationship between intraocular pressure (IOP)-lowering success of selective laser trabeculoplasty (SLT) and combined phacoemulsification/Kahook Dual Blade (phaco/KDB) goniotomy in eyes with mild to severe open angle glaucoma (OAG). METHODS: Eyes undergoing combined phaco/KDB goniotomy and that had previously undergone SLT were analyzed. Data collected included demographics, glaucoma type and severity, IOP, and topical IOP-lowering medications before and after both procedures. Eyes were divided into two groups based on success of SLT, defined as IOP reduction of at least 20% maintained on at least two consecutive follow-up visits without any subsequent medication additions or interventions. Phaco/KDB goniotomy success was defined as IOP reduction of at least 20% and/or reduction in the number of IOP-lowering medications of at least one up to 12 months of follow-up. RESULTS: Overall, SLT was successful in 20 of 43 eyes (46.5%), of which 63.6% (7/11) had successful phaco/KDB goniotomy at 12 months follow-up. Among eyes with unsuccessful SLT, 60.0% (9/15) had successful phaco/KDB at 12 months follow-up. Phaco/KDB success rate was similar in patients regardless of their previous response to SLT at all postoperative time points up to 12 months follow-up (p = 0.87). CONCLUSIONS: The presence or lack of IOP-lowering response to SLT did not influence the success rate of subsequent phaco/KDB goniotomy in eyes with mild to severe OAG. Patients who did not respond to SLT still benefited from phaco/KDB goniotomy at a later date. Springer Healthcare 2022-08-03 2022-10 /pmc/articles/PMC9437157/ /pubmed/35922711 http://dx.doi.org/10.1007/s40123-022-00554-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Phillips, Stephen S.
Patnaik, Jennifer L.
Capitena Young, Cara E.
Ertel, Monica K.
SooHoo, Jeffrey R.
Seibold, Leonard K.
Kahook, Malik Y.
Pantcheva, Mina B.
Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title_full Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title_fullStr Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title_full_unstemmed Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title_short Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy
title_sort selective laser trabeculoplasty and outcomes of subsequent phacoemulsification combined with kahook dual blade goniotomy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437157/
https://www.ncbi.nlm.nih.gov/pubmed/35922711
http://dx.doi.org/10.1007/s40123-022-00554-3
work_keys_str_mv AT phillipsstephens selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT patnaikjenniferl selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT capitenayoungcarae selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT ertelmonicak selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT soohoojeffreyr selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT seiboldleonardk selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT kahookmaliky selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy
AT pantchevaminab selectivelasertrabeculoplastyandoutcomesofsubsequentphacoemulsificationcombinedwithkahookdualbladegoniotomy